AERI
Aerie Pharmaceuticals Inc
Price:  
15.25 
USD
Volume:  
1,206,400.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Aerie EV/EBITDA

-177.4%
Upside

As of 2026-11-15, the EV/EBITDA ratio of Aerie Pharmaceuticals Inc (AERI) is -58.69. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Aerie's latest enterprise value is 1,012.11 mil USD. Aerie's TTM EBITDA according to its financial statements is -17.25 mil USD. Dividing these 2 quantities gives us the above Aerie EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 17.0x - 21.0x 20.0x
Forward P/E multiples 15.6x - 18.4x 17.7x
Fair Price (11.18) - (11.66) (11.81)
Upside -173.3% - -176.5% -177.4%
15.25 USD
Stock Price
(11.81) USD
Fair Price

Aerie EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA